Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine

Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine

Abstract Background Ergot-derived dopamine agonists are thought to induce fibrotic changes in cardiac valve leaflets. We sought to determine the incidence of heart valve disease in women treated with bromocriptine compared with age and sex matched controls from the background population. Methods In...

Full description

Bibliographic Details
Main Authors: Marianne F. Clausen, Rasmus Rørth, Christian Torp-Pedersen, Lucas Malta Westergaard, Peter E. Weeke, Gunnar Gislason, Lars Køber, Emil Fosbøl, Søren Lund Kristensen
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Cardiovascular Disorders
Subjects:
Bromocriptine
Ergot-derived dopamine agonist
Heart valve disease
Hyperprolactinemia
Online Access:https://doi.org/10.1186/s12872-021-02439-y

Internet

https://doi.org/10.1186/s12872-021-02439-y

Similar Items